We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
10577 Results

Congress Abstract

Subdomains of erectile and urinary function after ultrafocal HDR-brachytherapy for prostate cancer
Authors:

Max Peters1, Marieke van Son2, Marinus Moerland2, Jan Lagendijk2, Taimur Shah3, Hashim Ahmed3, Jochem van der Voort van Zyp2

1University Medical Center Utrecht, Department of Radiation Oncology, Utrecht, The Netherlands; 2UMC Utrecht, Department of Radiation Oncology, Utrecht, The Netherlands; 3Imperial College London, Department of Urology, London, United Kingdom

Show Affiliations
2021
Poster
WCB 2021 - Online

Congress Abstract

Lung SABRT treatment in oligometastatic patients, a prospective review
Authors: Csiki|, Emese(1)*[emesecsiki@yahoo.com];Simon|, Mihály(1,2);Papp|, Judit(1,2);Kovács|, Árpád(1,2);
(1)University of Debrecen, Clinic of Oncoradiology, Debrecen, Hungary;(2)University of Pécs, Faculty of Health Sciences- Doctoral School of Health Sciences, Pécs, Hungary;
Show Affiliations
2020
Poster
ESTRO 2020

Journal Article

First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer
Authors: Luise A. Künzel, Marcel Nachbar, Markus Hagmüller, Cihan Gani, Simon Boeke, Daniel Zips, Daniela Thorwarth
2021
Radiotherapy and Oncology

Journal Article

Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer
Authors: Laura Patricia Kaplan, Anne Ivalu Sander Holm, Jesper Grau Eriksen, Ben J.M. Heijmen, Stine Sofia Korreman, Linda Rossi
2023
Radiotherapy and Oncology

Congress Abstract

Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two population-based cohorts
Authors:

Pernille Lassen1, Shao Hui Huang2, Jie Su3, Brian O'Sullivan2, John Waldron4, Maria Andersen5, Hanne Primdahl6, Jørgen Johansen7, Claus Andrup Kristensen8, Elo Andersen9, Jesper Eriksen10, Christian Rønn Hansen11, Jan Alsner12, Jacob Lilja-Fisher12, Scott V. Bratman2, Jolie Ringash2, John Kim2, Andrew Hope2, Anna Spreafico13, John de Almeida14, Wei Xu15, Jens Overgaard12

1Aarhus University Hospital, Department of Experimental Clinical Oncology and Department of Oncology, Aarhus, Denmark; 2Princess Margaret Cancer Centre, Department of Radiation Oncology, Toronto, Canada; 3Princess Margaret Cancer centre, Department of Biostatistics, Toronto, Canada; 4Princess Margaret Cancer centre, Department of Radiation Oncology, Toronto, Canada; 5Aalborg University Hospital, Department of Oncology, Aalborg, Denmark; 6Aarhus University Hospital, Department of Oncology, Aarhus, Denmark; 7Odense University Hospital, Department of Oncology, Odense, Denmark; 8Copenhagen University Hospital, Department of Oncology, Copenhagen, Denmark; 9Herlev Hospital, Copenhagen, Department of Oncology, Copenhagen, Denmark; 10Aarhus University Hospital, Department of Experimental Oncology and Department of Oncology, Aarhus, Denmark; 11Odense University Hospital, Laboratory of Radiation Physics, Odense, Denmark; 12Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark; 13Princess Margaret Cancer Centre, Department of Medical Oncology, Toronto, Canada; 14Princess Margaret Cancer Centre, Department of Otolaryngology - Head and Neck Surgery, Toronto, Canada; 15Princess Margaret Cancer Centre, Department of Biostatistics, Toronto, Canada

Show Affiliations
2021
Poster highlight
ESTRO 2021

Congress Abstract

Multimodal anthropomorphic abdomen phantom with real-time breathing motion for IGRT
Authors:

Christina Stengl1, Artur Weidner1,2, Fabian Dinkel1, Stefan Dorsch1, Armin Runz1,3, Gernot Echner1,4

1German Cancer Research Center (DKFZ), Medical Physics in Radiation Oncology, Heidelberg, Germany; 2Heidelberg University, Faculty of Medicine, Heidelberg, Germany; 3Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany; 4 Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany

Show Affiliations
2021
Poster Discussion
ESTRO 2021

Webcast

The immune microenvironment in lung cancer - impact on effect of combined radiotherapy and immunotherapy?
Authors: Åslaug Helland
2020
ESTRO 2020 - Online congress

Congress Abstract

Pencil Beam Proton Flash Therapy, the challenge of scanning.
Authors:

Arnaud Pin1, Lucian Hotoiu1, Sylvain Deffet2, Edmond Sterpin2,3, Rudi Labarbe1

1Ion Beam Applications, Research, Louvain-la-Neuve, Belgium; 2Université Catholique de Louvain, Imagerie Médicale, Radiothérapie et Oncologie, Louvain-la-Neuve, Belgium; 3KU Leuven, Laboratorium Experimentele Radiotherapie, Leuven, Belgium

Show Affiliations
2021
Poster Discussion
ESTRO 2021

Congress Abstract

European multi-centric study on variable proton RBE dose calculations for multiple anatomical sites
Authors:

Christian Hahn1,2,3,4, Jakob Ödén5, Alexandru Dasu6,7, Anne Vestergaard8, Jesper Folsted Kallehauge8, Claudia Pardi9, Faiza Bourhaleb9, Amélia Leite10, Ludovic de Marzi10,11, Edward Smith12,13, Adam Aitkenhead12,13, Michael Merchant12,13, Karen Kirkby12,13, Esther G. C. Troost1,2,3,14,15, Armin Lühr1,3,4,14

1OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; 2Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 3German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 4Medical Physics and Radiotherapy, Faculty of Physics, TU Dortmund University, Dortmund, Germany; 5RaySearch Laboratories AB, Research, Stockholm, Sweden; 6The Skandion Clinic, Radiation Oncology, Uppsala, Sweden; 7Medical Radiation Sciences, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; 8Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; 9I-SEE, Internet-Simulation Evaluation Envision, Torino, Italy; 10Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre Universitaire, 91898 Orsay, France; 11Institut Curie, PSL Research University, University Paris Saclay, Inserm LITO, 91898 Orsay, France; 12Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United Kingdom; 13Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; 14Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany; 15National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany , and; Helmholtz Association / Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany

Show Affiliations
2021
Oral
ESTRO 2021

Congress Abstract

Patients’ preferences on breast cancer side effects communication: implications for a decision aid
Authors:

Hajar Hasannejadasl1, Liesbeth Boersma1, Carol Richel2, Maaike Schuurman2, Rianne Fijten1, Cheryl Roumen1

1Maastro, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands, Maastricht, The Netherlands; 2Breast Cancer Foundation Netherlands, Shared decision making, Utrecht, The Netherlands

Show Affiliations
2021
Poster Discussion
ESTRO 2021
*:*